Perhexilene
Brand names,
Perhexilene
Analogs
Perhexilene
Brand Names Mixture
Perhexilene
Chemical_Formula
C19H35N
Perhexilene
RX_link
No information avaliable
Perhexilene
fda sheet
Perhexilene
msds (material safety sheet)
Perhexilene
Synthesis Reference
No information avaliable
Perhexilene
Molecular Weight
277.488 g/mol
Perhexilene
Melting Point
No information avaliable
Perhexilene
H2O Solubility
0.0608 mg/L
Perhexilene
State
Solid
Perhexilene
LogP
6.054
Perhexilene
Dosage Forms
Tablet for oral administration (100 mg)
Perhexilene
Indication
For the management of severe angina pectoris.
Perhexilene
Pharmacology
Used in the treatment of unresponsive or refractory angina. Perhexiline increases glucose metabolism at the expense of free-fatty-acid metabolism, enhancing oxygen efficiency during myocardial ischaemia. Perhexiline also potentiates platelet responsiveness to nitric oxide both in patients with angina and patients with acute coronary syndrome. The predominant mechanism of this particular perhexiline effect is an increase in platelet cGMP responsiveness. Perhexiline also may reduce the potential for nitric oxide clearance by neutrophil-derived oxygen. Perhexiline relieves symptoms of angina, improves exercise tolerance, and increases the workload needed to induce ischaemia when used as monotherapy. The primary therapeutic roles for perhexiline are as short-term therapy (less than 3 months duration) in patients with severe ischaemia awaiting coronary revascularisation or long-term therapy in patients with ischaemic symptoms refractory to other therapeutic measures.
Perhexilene
Absorption
Well absorbed (>80%) from the gastrointestinal tract following oral administration.
Perhexilene
side effects and Toxicity
Oral LD50 Rat: 2150 mg/kg; Oral LD50 Mouse: 2641 mg/kg. Short term adverse effects include nausea, transient dizziness, hypoglycaemia in diabetic patients, and torsade de pointes (rare).
Perhexilene
Patient Information
No information avaliable
Perhexilene
Organisms Affected
Humans and other mammals